Key takeaways:
Entresto (sacubitril / valsartan) is a medication that treats heart failure. The most common Entresto side effect is low blood pressure, which can cause dizziness. Other possible side effects include cough and increased potassium levels.
More severe side effects, such as very low blood pressure, extremely high potassium levels, and kidney problems are rare but also possible.
Having certain health conditions or taking certain medications can increase your risk of side effects from Entresto. So give your prescriber your full medical history and medication list before starting Entresto.
Entresto (sacubitril / valsartan) has been hailed as a “game changer” medication for treating heart failure since its approval in 2015. It’s the first medication of its kind: a combination of an angiotensin II receptor blocker (valsartan) and neprilysin inhibitor (sacubitril).
Entresto is a first-choice medication for treating heart failure. But like nearly all medications, side effects are possible. Here, we’ll take a close look at five Entresto side effects.
Entresto is generally well tolerated. Still, possible Entresto side effects include:
Low blood pressure
High potassium levels
Cough
Dizziness
Entresto can also lead to more serious risks, such as:
Severely low blood pressure
Severely high potassium levels
Kidney problems
Swelling of deep tissues (angioedema)
This medication also has a boxed warning for birth defects if taken while pregnant. A boxed warning is the FDA’s strictest warning for medications.
Before starting Entresto, make sure your prescriber knows your full health history and other medications you take. This will help them decide whether Entresto is right for you.
Hypotension (low blood pressure) is the most commonly reported Entresto side effect. This side effect isn’t surprising, though. Valsartan, one of the medications in Entresto, is prescribed to lower blood pressure. It’s part of a group of medications called ARBs. These medications are prescribed for hypertension (high blood pressure), heart failure, and more.
Certain factors increase your risk of low blood pressure. This includes being of older age, having low blood pressure prior to Entresto treatment, and taking other medications that lower blood pressure.
Entresto basics: Learn how Entresto works and what type of heart failure it treats.
Generic Entresto: Entresto isn’t available as a generic yet, but it may become available soon.
Taking Entesto: The typical Entresto dosage is 1 tablet twice daily.
Symptoms of low blood pressure include feeling dizzy, lightheaded, or weak. Let your prescriber know if you experience any of these symptoms. They may recommend lowering your Entresto dosage or the dosage of other medications. But don’t make any changes without talking to your prescriber first.
Hyperkalemia (high potassium levels) is another possible Entresto side effect. Potassium is a mineral you get from food. It plays an essential role in many bodily functions. For example, potassium helps your heart work efficiently and regulates blood pressure.
Some people may be at an increased risk for hyperkalemia from Entresto. This includes people who:
Have certain health conditions, such as diabetes, kidney damage, or low aldosterone (hypoaldosteronism)
Consume a diet that's high in potassium
Take medications that can increase potassium levels, including spironolactone (Aldactone) and potassium supplements
Symptoms of high potassium can include nausea, muscle weakness, and fatigue. But high potassium often doesn’t cause symptoms until it becomes very high (6 mEq/L or more). Very high potassium levels can cause arrhythmia (irregular heartbeat) and be life-threatening.
Your prescriber will likely monitor your potassium levels with a blood test before and during treatment with Entresto. If your potassium levels increase, your prescriber may lower your Entresto dosage. Or they may recommend another medication altogether.
Developing a dry cough is another possible Entresto side effect. This is due to the valsartan component. All ARBs, including valsartan, may cause a dry, hacking cough.
But this is much less common with ARBs than it is with angiotensin-converting enzyme (ACE) inhibitors, another group of common blood pressure medications. For example, in the PARADIGM-HF study — the major study that led to Entresto’s FDA approval — cough was more common with the angiotensin-converting enzyme (ACE) inhibitor enalapril (Vasotec, Epaned) than it was with Entresto.
Let your cardiologist know if you develop a dry cough that doesn’t go away while you’re taking Entresto. They can help you figure out if this is due to Entresto, or related to something else.
Entresto may cause worsening kidney function or even sudden kidney failure. It’s rare, though. In fact, ARBs like valsartan help protect the kidneys in many cases. Still, kidney damage from Entresto is possible, so it’s a good idea to know what symptoms to watch out for. Examples include:
Producing little or no urine
Swelling in your ankles or lower legs
Tiredness
Feeling short of breath
Confusion
Nausea
If you have existing kidney problems, you may be at higher risk for kidney-related side effects from Entresto. So be sure your prescriber knows your complete medical history. And let them know what other medications you take as well. Taking certain medications with Entresto can increase your risk of kidney damage. This includes non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen (Advil, Motrin).
If you take Entresto, your prescriber will order lab tests (such as a creatinine blood test) to check your kidney function before and after starting treatment. If your kidney function is already lower than expected, they may start you at a lower Entresto dosage. If your kidney function worsens after starting this medication, you may need to lower your dose or switch to another medication entirely.
Angioedema (swelling of deep tissues) is a rare but serious Entresto side effect. It typically presents in areas of the face, like the lips. It can also occur in the throat and neck. In severe cases, it can cause trouble breathing that’s life-threatening.
In the PARADIGM-HF study, Black people were more likely to experience angioedema from Entresto. You’re also at increased risk if you’ve experienced angioedema in the past. So Entresto isn’t recommended if you’ve ever had angioedema (even if it was from another medication, such as an ACE inhibitor).
If you experience swelling of your face, lips, tongue, or throat, or trouble breathing while taking Entresto, stop taking it and call 911 or go to the nearest ER. Most cases of angioedema resolve on their own, but if you develop trouble breathing you’ll need immediate medical care.
There are a few situations where Entresto isn’t recommended. This includes people who:
Have an allergy to Entresto
Have a history of angioedema
Take an ARB or ACE inhibitor
Have diabetes and take aliskiren (Tekturna)
Are pregnant or breastfeeding
Whose blood pressure is too low
Have severe liver problems
Can’t reliably obtain or afford Entresto, which may lead to inconsistent use
The term “heart failure” may sound grave, but with proper treatment, people with heart failure can live normal lives.
How long you can live with heart failure depends on many factors, including your age and other health conditions you have. It also depends on how your heart failure is treated. Using the correct combination of medications can help you live longer and significantly improve your quality of life. Heart healthy lifestyle choices are also very important, such as quitting smoking and following a heart-healthy diet, and managing sleep apnea if you have it.
Most people will take a combination of medications to treat heart failure, which may or may not include Entresto. While there is no direct alternative to Entresto, other medications that treat heart failure include:
ARBs, such as losartan (Cozaar)
ACE inhibitors, such as lisinopril (Zestril)
Beta blockers, such as carvedilol (Coreg)
Diuretics (water pills), such as furosemide (Lasix)
Aldosterone blockers, such as spironolactone (Aldactone)
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, such as empagliflozin (Jardiance)
No, Entresto isn’t a blood thinner. Entresto contains two medications, valsartan and sacubitril. Neither of these medications are blood thinners. While blood thinners aren’t typically used to treat heart failure itself, you may benefit from one if you have other heart conditions such as atrial fibrillation. Blood thinner medications (called anticoagulants) include apixaban (Eliquis), rivaroxaban (Xarelto), and warfarin (Jantoven).
Entresto is a medication that treats heart failure. It contains two active ingredients: valsartan and sacubitril.
Entresto is a first-choice medication for many people with heart failure. It’s generally well tolerated. But side effects are also possible, so it helps to know what to watch out for. The most common Entresto side effect is low blood pressure, which can lead to dizziness. High potassium levels (hyperkalemia), kidney problems, and angioedema (swelling of deep tissues) are rare, but can also occur.
Before starting Entresto, make sure your prescriber knows your full health history and other medications you take. This will help them decide whether Entresto is the right option for you.
American Heart Association. (2023). Medications used to treat heart failure.
American Kidney Fund. (2022). Acute kidney injury (AKI).
Ding, H., et al. (2020). Drug-induced chronic cough and the possible mechanism of action. Annals of Palliative Medicine.
Heidenrich, P. A., et al. (2022). 2022 AHA/ACC/HFSA guideline for the management of heart failure: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation.
McMurray, J. J. V., et al. (2014). Angiotensin–neprilysin inhibition versus enalapril in heart failure. The New England Journal of Medicine.
Memon, R. J., et al. (2023). Angioedema. StatPearls.
Mukherjee, S. (2015). Novartis set to redraw the heart failure map with rapid approval of game-changer Entresto. BioPharma Dive.
Novartis. (2024). Entresto (sacubitril and valsartan) tablets, for oral use [package insert].
Tomson, C. R. V., et al. (2021). Management of blood pressure in patients with chronic kidney disease not receiving dialysis: Synopsis of the 2021 KDIGO clinical practice guideline. Annals of Internal Medicine.
Vardeny, O., et al. (2018). Incidence, predictors, and outcomes associated with hypotensive episodes among heart failure patients receiving sacubitril/valsartan or enalapril: The PARADIGM-HF trial (prospective comparison of angiotensin receptor neprilysin inhibitor with angiotensin-converting enzyme inhibitor to determine impact on global mortality and morbidity in heart failure). Circulation: Heart Failure.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.